The Ministry of Health of the Canary Islands has resumed the administration of the AstraZeneca vaccine with the inclusion of the population under 65 years of age, prioritizing people between 60 and 65 years old. This has been reported by the regional Government, who adds that this restart is carried out with the guarantees of safety and efficacy from the scientific evidence of the Committee for the Evaluation of Risks in Pharmacovigilance (PRAC) of the European Agency of Medicines (EMA), the Public Health Commission and recent UK observational studies.
In addition to continuing to vaccinate large household dependents and those over 80 with a second dose of Pfizer or Moderna vaccines, inoculation was resumed yesterday with AstraZeneca for the 144,000 people who are between 60 and 65 years old in the Canary Islands. This is, the first time they are starting vaccinations by age, and not only by risk groups, and those over 65 will be next with the Pfizer and Moderna vaccines which will also incorporate the Janssen single dose vaccine next month.
